» Articles » PMID: 8723850

Comparative Absorption Kinetics of Intramuscular Midazolam and Diazepam

Overview
Journal Can J Anaesth
Specialty Anesthesiology
Date 1996 May 1
PMID 8723850
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study investigates the rate and extent of absorption following intramuscular injection of midazolam and diazepam.

Methods: Four healthy male volunteers were recruited in this randomized three-way cross-over study. On one occasion each subject received simultaneous im injections of 5 mg midazolam and 10 mg diazepam in separate deltoid muscles. On two other separate occasions each subject received an iv infusion of 7.5 mg midazolam and 30 mg diazepam over five minutes. Frequent arterial blood samples were collected for up to two hours and venous blood samples were collected for up to 24 hours for midazolam and ten days for diazepam. A gas chromatography assay was used to determine the plasma concentrations of midazolam and diazepam. The im absorption profiles were estimated using constrained least-squares deconvolution.

Results: There were substantial intersubject variabilities in the estimated pharmacokinetic parameters (volume and clearances) of intravenous midazolam and diazepam. The mean (+/-sd) time to peak plasma concentration (Cmax) was shorter for im midazolam (17.5 +/- 6.5 min) relative to diazepam (33.8 +/- 7.5 min). The mean (+sd) time to peak absorption rate was also shorter for midazolam (9 +/- 2 vs 13.8 +/- 7.5 min). The peak rate of absorption was identical (0.18 mg. min-1) and bioavailability was 1.0 for both drugs.

Conclusions: We conclude that midazolam has more rapid absorption than diazepam following im administration.

Citing Articles

Intravenous and Intramuscular Formulations of Antiseizure Drugs in the Treatment of Epilepsy.

Patel S, Birnbaum A, Cloyd J, Leppik I CNS Drugs. 2015; 29(12):1009-22.

PMID: 26603741 DOI: 10.1007/s40263-015-0289-0.


Implementation of the exception from informed consent regulations in a large multicenter emergency clinical trials network: the RAMPART experience.

Silbergleit R, Biros M, Harney D, Dickert N, Baren J Acad Emerg Med. 2012; 19(4):448-54.

PMID: 22506949 PMC: 3335290. DOI: 10.1111/j.1553-2712.2012.01328.x.


Challenges in the design and analysis of non-inferiority trials: a case study.

Durkalski V, Silbergleit R, Lowenstein D Clin Trials. 2011; 8(5):601-8.

PMID: 21921062 PMC: 6771014. DOI: 10.1177/1740774511418848.


Treatment of patients with cocaine-induced arrhythmias: bringing the bench to the bedside.

Hoffman R Br J Clin Pharmacol. 2010; 69(5):448-57.

PMID: 20573080 PMC: 2856045. DOI: 10.1111/j.1365-2125.2010.03632.x.


Bispectral index during epidural puncture predicts anterograde amnesia in patients given midazolam premedication.

Nakasuji M, Nakamura M, Imanaka N, Tanaka M, Nomura M, Wada M J Anesth. 2009; 23(3):329-33.

PMID: 19685110 DOI: 10.1007/s00540-009-0748-1.

References
1.
Divoll M, Greenblatt D, Ochs H, Shader R . Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex. Anesth Analg. 1983; 62(1):1-8. View

2.
Greenblatt D, Ochs H, Lloyd B . Entry of diazepam and its major matabolite into cerebrospinal fluid. Psychopharmacology (Berl). 1980; 70(1):89-93. DOI: 10.1007/BF00432376. View

3.
Verotta D . An inequality-constrained least-squares deconvolution method. J Pharmacokinet Biopharm. 1989; 17(2):269-89. DOI: 10.1007/BF01059031. View

4.
Bell D, Richards G, Dhillon S, Oxley J, Cromarty J, Sander J . A comparative pharmacokinetic study of intravenous and intramuscular midazolam in patients with epilepsy. Epilepsy Res. 1991; 10(2-3):183-90. DOI: 10.1016/0920-1211(91)90011-4. View

5.
Streisand J, Varvel J, Stanski D, LE MAIRE L, Ashburn M, Hague B . Absorption and bioavailability of oral transmucosal fentanyl citrate. Anesthesiology. 1991; 75(2):223-9. DOI: 10.1097/00000542-199108000-00009. View